Shropshire Star
Close

Shropshire NHS called to act over cause of ‘twice as many deaths as breast cancer’

NHS trusts in Shropshire have been called to action against the rising global risk of antimicrobial resistance (AMR).

By David Tooley
Published

AMR, which can make infections impossible to treat, has been nationally linked with causing twice as many deaths as breast cancer each year.

Get the latest headlines delivered straight to your inbox with the Shropshire Star’s free newsletter

File photo dated 08/11/06 of a woman taking a tablet. Academics called on GPs to "better target" antibiotics for those at highest need after analysing data on millions of prescriptions over a number of years. There have been a number of measures in
File photo dated 08/11/06 of a woman taking a tablet. Academics called on GPs to "better target" antibiotics for those at highest need after analysing data on millions of prescriptions over a number of years. There have been a number of measures in

“Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines,” writes Paula Gardner, chief nursing officer at the Shrewsbury & Telford Hospital NHS Trust (SaTH).

“The resultant effect of antimicrobial resistance is that antibiotics and other antimicrobial medicines become ineffective, and infections become difficult or impossible to treat.

“Infections that are difficult or impossible to treat increase the risk of disease spread, severe illness, disability and death.”

SaTH, along with other health trusts and commissioning organisations, has been sent a letter by NHS England about increasing global concerns.

The letter says that the World Health Organisation (WHO) has declared antimicrobial resistance as a top global health and development threat and it is in the Government’s Risk Register.

Members of Sath’s board will be told at a meeting on Thursday that they have to agree and publish three priority areas for improvement by April 2026.

Proposals for these include reviewing antimicrobial prescriptions after two days, switching patients from intravenous to oral antibiotics, and reducing delays in spotting infections.